FDA expands AI pilot

FDA Looks to Expand Real-Time Drug Clinical Trials

The FDA seeks input to expand an AI-driven pilot program enabling real-time data submission for clinical trials, currently testing drugs for lymphoma and lung cancer with partners like AstraZeneca and